MétaCan
Menu
Cohort builder

4,299,418 works, Canadian by any of four routes.

Every filter state is a URL; the URL is the query; the query is citable via /q/⟨hash⟩. The page, the API and the export parse the same parameters.

The current cohort, streamed from the database: every work column, the machine labels, the provisional scores, and the per-row validation status. Exports are capped at 100,000 rows. Mints a permanent /q/ link for this exact query. The same filters always produce the same link, whoever asks.

Search term
Author
Year range
Sort
Language
Type
Field
Venue
Topic
Prostate Cancer Treatment and Research
Retraction
Abstract
Evidence source
Study design
Label agreement
Label status

Direct Codex and Gemma labels are unvalidated and sparse. Distilled predictions cover the full frame and are also unvalidated. Choose the evidence source explicitly; absence of a direct label is never a negative label.

affaffiliation
fundfunder
venuejournal
aboutaboutness

The four routes compose: require the funder route and exclude affiliation to get the funder-only stratum no affiliation-based frame ever sees.

3,880 results · 1 filter active ·
Results by year
20002025
Publication date
Categories
Machine labels · sparse coverage
Evidence
Language
Type
Citations
An unlabeled work is unknown, not a negative. Label coverage is reported on every query.
3,880 works in the cohort · of 4,299,418page 1 of 78

Labels cover 13 of 3,880 works in this cohort. The rest are unlabeled, which is not a negative label: the label table is sparse today and grows as labeling rounds land.

Distilled predictions cover 3,880 of 3,880 works in this cohort. Predictions are machine_predicted_unvalidated. The Gemma side is a direct model label for every work (title-only); the Codex side is a distilled, calibrated classifier. Candidate is the union; consensus is the intersection.

afffundunlabeled
Enzalutamide in Metastatic Prostate Cancer before Chemotherapy
Tomasz M. Beer, Andrew J. Armstrong, Dana E. Rathkopf, Yohann Loriot, Cora N. Sternberg, Celestia S. Higano +22 more
2014· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
3,031
citations
affunlabeled
Olaparib for Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono, Joaquı́n Mateo, Karim Fizazi, Fred Saad, Neal D. Shore, Shahneen Sandhu +14 more
2020· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
2,237
citations
fundno affunlabeled
DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer
Joaquı́n Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Pérez-López +45 more
2015· article· en· New England Journal of Medicine· Medicine
machine prediction:candidate · noneconsensus · none
2,187
citations
affno abstractunlabeled
Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study
Charles J. Ryan, Matthew R. Smith, Karim Fizazi, Fred Saad, Peter F.A. Mulders, Cora N. Sternberg +19 more
2015· article· en· The Lancet Oncology· Medicine
machine prediction:candidate · noneconsensus · none
1,354
citations
affno abstractunlabeled
Prostate cancer
Richard J. Rebello, Christoph Oing, Karen E. Knudsen, Stacy Loeb, David C. Johnson, Robert E. Reiter +3 more
2021· review· en· Nature Reviews Disease Primers· Medicine
machine prediction:candidate · noneconsensus · none
1,109
citations
affno abstractunlabeled
Prostate cancer
Gerhardt Attard, Chris Parker, Rosalind A. Eeles, Fritz H. Schröder, Scott A. Tomlins, Ian F. Tannock +2 more
2015· review· en· The Lancet· Medicine
machine prediction:candidate · noneconsensus · none
917
citations
affunlabeled
Human prostate cancer risk factors
David G. Bostwick, Harry Burke, Daniel Djakiew, Susan Y. Euling, Shuk‐Mei Ho, Joseph R. Landolph +5 more
2004· review· en· Cancer· Medicine
machine prediction:candidate · noneconsensus · none
650
citations
affno abstractunlabeled
Genomic hallmarks of localized, non-indolent prostate cancer
Michael Fraser, Veronica Y. Sabelnykova, Takafumi N. Yamaguchi, Lawrence E. Heisler, Julie Livingstone, Vincent Huang +64 more
2017· article· en· Nature· Medicine
machine prediction:candidate · noneconsensus · none
640
citations
fundno affunlabeled
Plasma <i>AR</i> and abiraterone-resistant prostate cancer
Alessandro Romanel, Delila Gasi Tandefelt, Vincenza Conteduca, Anuradha Jayaram, Nicola Casiraghi, Daniel Wetterskog +17 more
2015· article· en· Science Translational Medicine· Medicine
machine prediction:candidate · noneconsensus · none
441
citations

How this was built: Screen · Findings · About